These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15871560)

  • 1. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
    Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
    Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.
    Schelwies K; Sturm I; Grabowski P; Scherübl H; Schindler I; Hermann S; Stein H; Buhr HJ; Riecken EO; Zeitz M; Dörken B; Daniel PT
    Int J Cancer; 2002 Jun; 99(4):589-96. PubMed ID: 11992551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bcl-2 protein expression is associated with better prognosis in colorectal cancer.
    Leahy DT; Mulcahy HE; O'Donoghue DP; Parfrey NA
    Histopathology; 1999 Oct; 35(4):360-7. PubMed ID: 10564391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
    Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
    Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
    Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
    Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
    Tollenaar RA; van Krieken JH; van Slooten HJ; Bruinvels DJ; Nelemans KM; van den Broek LJ; Hermans J; van Dierendonck JH
    Br J Cancer; 1998 Jun; 77(11):1842-7. PubMed ID: 9667656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage.
    Georgiou L; Minopoulos G; Lirantzopoulos N; Fiska-Demetriou A; Maltezos E; Sivridis E
    J Surg Res; 2006 Mar; 131(1):118-23. PubMed ID: 16325858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.
    Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
    Br J Cancer; 1999 Jun; 80(7):1075-9. PubMed ID: 10362119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy.
    Brewster SF; Oxley JD; Trivella M; Abbott CD; Gillatt DA
    J Urol; 1999 Apr; 161(4):1238-43. PubMed ID: 10081877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
    Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
    Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
    Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
    Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
    Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
    Singson RP; Alsabeh R; Geller SA; Marchevsky A
    Mod Pathol; 1999 May; 12(5):479-84. PubMed ID: 10349985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.